Also, if these effects were to be disrupted by inhibitors of the other receptor, we hypothesized that this would be due to inhibition of IL-6 release, which we had identified as a central factor mediated by both receptors and known to be a major factor in disrupting the gut epithelial barrier in human IBD and in DSS colitis models [70,71]. The gene discussed is IL6; the disease is inflammatory bowel disease.